Vivian Fonseca, MD, Endocrinology, New Orleans, LA, Tulane-Lakeside Hospital

VivianAndrewFonsecaMD

Endocrinology New Orleans, LA

Diabetes, Lipid Metabolism

Professor of Medicine, Tulane University

Dr. Fonseca is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Fonseca's full profile

Already have an account?

Education & Training

  • Tulane University School of Medicine
    Tulane University School of MedicineClass of 1974

Certifications & Licensure

  • LA State Medical License
    LA State Medical License 1998 - 2021
  • NY State Medical License
    NY State Medical License 1993 - 2018
  • AR State Medical License
    AR State Medical License 1993 - 2021
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
  • Super Doctor SuperDoctors.com
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • The Intersection of Heart Failure and Diabetes 
    2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019
  • A Model‐Based Meta‐Analysis of 24 Antihyperglycemic Drugs for Type 2 Diabetes: Comparison of Treatment Effects at Therapeutic Doses 
    New Orleans, LA - 6/15/2014
  • A Model‐Based Meta‐Analysis of 24 Antihyperglycemic Drugs for Type 2 Diabetes: Comparison of Treatment Effects at Therapeutic Doses 
    Vivian Fonseca, MD - 6/13/2014

Press Mentions

  • Biography: Shashank Shah, MBBS, MS, FAIS, FICS
    Biography: Shashank Shah, MBBS, MS, FAIS, FICSJanuary 07, 2021 12:30
  • Serum Visceral Adipose Tissue–Derived Serine Protease Inhibitor Concentrations in Human Obesity and Polycystic Ovary Syndrome
    Serum Visceral Adipose Tissue–Derived Serine Protease Inhibitor Concentrations in Human Obesity and Polycystic Ovary SyndromeDecember 07, 2018 20:18
  • The Fukushima Legacy, Diabetes Diagnoses Have Increased Six-Fold
    The Fukushima Legacy, Diabetes Diagnoses Have Increased Six-FoldJuly 04, 2018 17:19
  • Join now to see all

Committees

  • member, CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM 2016 EXECUTIVE SUMMARY
  • member, AACE/ACE Comprehensive Type 2 Diabetes Management Algorithm 2026

Hospital Affiliations